226 related articles for article (PubMed ID: 20359356)
1. Stochastic modeling of B lymphocyte terminal differentiation and its suppression by dioxin.
Zhang Q; Bhattacharya S; Kline DE; Crawford RB; Conolly RB; Thomas RS; Kaminski NE; Andersen ME
BMC Syst Biol; 2010 Apr; 4():40. PubMed ID: 20359356
[TBL] [Abstract][Full Text] [Related]
2. A bistable switch underlying B-cell differentiation and its disruption by the environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Bhattacharya S; Conolly RB; Kaminski NE; Thomas RS; Andersen ME; Zhang Q
Toxicol Sci; 2010 May; 115(1):51-65. PubMed ID: 20123757
[TBL] [Abstract][Full Text] [Related]
3. Involvement of Blimp-1 and AP-1 dysregulation in the 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated suppression of the IgM response by B cells.
Schneider D; Manzan MA; Yoo BS; Crawford RB; Kaminski N
Toxicol Sci; 2009 Apr; 108(2):377-88. PubMed ID: 19237549
[TBL] [Abstract][Full Text] [Related]
4. All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Zhang Q; Kline DE; Bhattacharya S; Crawford RB; Conolly RB; Thomas RS; Andersen ME; Kaminski NE
Toxicol Appl Pharmacol; 2013 Apr; 268(1):17-26. PubMed ID: 23357550
[TBL] [Abstract][Full Text] [Related]
5. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
Sulentic CE; Holsapple MP; Kaminski NE
Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
[TBL] [Abstract][Full Text] [Related]
6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin-mediated impairment of B cell differentiation involves dysregulation of paired box 5 (Pax5) isoform, Pax5a.
Schneider D; Manzan MA; Crawford RB; Chen W; Kaminski NE
J Pharmacol Exp Ther; 2008 Aug; 326(2):463-74. PubMed ID: 18483191
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor-dependent inhibition of AP-1 activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin in activated B cells.
Suh J; Jeon YJ; Kim HM; Kang JS; Kaminski NE; Yang KH
Toxicol Appl Pharmacol; 2002 Jun; 181(2):116-23. PubMed ID: 12051995
[TBL] [Abstract][Full Text] [Related]
8. 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated suppression of toll-like receptor stimulated B-lymphocyte activation and initiation of plasmacytic differentiation.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2010 Jul; 116(1):99-112. PubMed ID: 20348231
[TBL] [Abstract][Full Text] [Related]
9. Putative link between transcriptional regulation of IgM expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin and the aryl hydrocarbon receptor/dioxin-responsive enhancer signaling pathway.
Sulentic CE; Holsapple MP; Kaminski NE
J Pharmacol Exp Ther; 2000 Nov; 295(2):705-16. PubMed ID: 11046109
[TBL] [Abstract][Full Text] [Related]
10. Aryl hydrocarbon receptor (AhR) agonists suppress interleukin-6 expression by bone marrow stromal cells: an immunotoxicology study.
Jensen BA; Leeman RJ; Schlezinger JJ; Sherr DH
Environ Health; 2003 Dec; 2(1):16. PubMed ID: 14678569
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
De Abrew KN; Phadnis AS; Crawford RB; Kaminski NE; Thomas RS
Toxicol Appl Pharmacol; 2011 Apr; 252(2):150-8. PubMed ID: 21296099
[TBL] [Abstract][Full Text] [Related]
12. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the regulation of Pax5 in lipopolysaccharide-activated B cells.
Yoo BS; Boverhof DR; Shnaider D; Crawford RB; Zacharewski TR; Kaminski NE
Toxicol Sci; 2004 Feb; 77(2):272-9. PubMed ID: 14600275
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous in vivo time course and dose response evaluation for TCDD-induced impairment of the LPS-stimulated primary IgM response.
North CM; Crawford RB; Lu H; Kaminski NE
Toxicol Sci; 2009 Nov; 112(1):123-32. PubMed ID: 19675145
[TBL] [Abstract][Full Text] [Related]
14. The immunotoxic effects of dual exposure to PCP and TCDD.
Chen HM; Lee YH; Chen RJ; Chiu HW; Wang BJ; Wang YJ
Chem Biol Interact; 2013 Nov; 206(2):166-74. PubMed ID: 24051191
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs human B lymphopoiesis.
Li J; Phadnis-Moghe AS; Crawford RB; Kaminski NE
Toxicology; 2017 Mar; 378():17-24. PubMed ID: 28049042
[TBL] [Abstract][Full Text] [Related]
16. An enzyme-linked immunosorbent assay (ELISA) specific for antibodies to TNP-LPS detects alterations in serum immunoglobulins and isotype switching in C57BL/6 and DBA/2 mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds.
Harper N; Connor K; Steinberg M; Safe S
Toxicology; 1994 Sep; 92(1-3):155-67. PubMed ID: 7940557
[TBL] [Abstract][Full Text] [Related]
17. SHP-1 is directly activated by the aryl hydrocarbon receptor and regulates BCL-6 in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).
Phadnis-Moghe AS; Li J; Crawford RB; Kaminski NE
Toxicol Appl Pharmacol; 2016 Nov; 310():41-50. PubMed ID: 27546522
[TBL] [Abstract][Full Text] [Related]
18. The aryl hydrocarbon receptor has a role in the in vivo maturation of murine bone marrow B lymphocytes and their response to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Thurmond TS; Staples JE; Silverstone AE; Gasiewicz TA
Toxicol Appl Pharmacol; 2000 Jun; 165(3):227-36. PubMed ID: 10860871
[TBL] [Abstract][Full Text] [Related]
19. Suppression of the IgM Response by Aryl Hydrocarbon Receptor Activation in Human Primary B Cells Involves Impairment of Immunoglobulin Secretory Processes.
Zhou J; Henriquez J; Crawford R; Kaminski N
Toxicol Sci; 2018 May; 163(1):319-329. PubMed ID: 29462421
[TBL] [Abstract][Full Text] [Related]
20. Selective effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin and corticosteroid on in vitro lymphocyte maturation.
Luster MI; Germolec DR; Clark G; Wiegand G; Rosenthal GJ
J Immunol; 1988 Feb; 140(3):928-35. PubMed ID: 3257509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
